Clinical Trial Update: A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 randomized, open-label study is evaluating losartan therapy to slow progression of aortic root dilation in patients with Marfan syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marfan Syndrome

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Marfan Syndrome | Phase 2 | Status: UNKNOWN